Status:
COMPLETED
Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)
Lead Sponsor:
Janssen-Cilag, S.A.
Conditions:
Cancer Pain
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.
Detailed Description
This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessmen...
Eligibility Criteria
Inclusion
- Patients =18 years old
- have medical data of = 3 months
- experience pain after cancer diagnosis and complete the Beck Depression Inventory (BDI)
- patients who give informed written consent
- patients with no mental or physical disorders that unable them to complete the BDI.
Exclusion
- Patients with diagnosis of depression before cancer diagnosis
- patients with chronic pain prior to the diagnosis of cancer, and cancer disease has not changed its course
- patients with other previous mental disorders
- patients who do not give their informed written consent.
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
271 Patients enrolled
Trial Details
Trial ID
NCT01402830
Start Date
November 1 2007
End Date
March 1 2008
Last Update
February 11 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.